Sex differences in cardiovascular disease risk in adolescents with type 1 diabetes
- PMID: 22795492
- PMCID: PMC3481996
- DOI: 10.1016/j.genm.2012.05.003
Sex differences in cardiovascular disease risk in adolescents with type 1 diabetes
Abstract
Background: Cardiovascular disease is seen at a younger age and at a higher prevalence in patients with type 1 diabetes than in the general population. It is well described that women with type 1 diabetes have a higher relative risk of cardiovascular disease than men with type 1 diabetes, unlike that seen in the general population. The pathophysiology behind this is unknown.
Objective: We performed a cross-sectional study to examine sex differences in cardiovascular disease risk factors in adolescents with type 1 diabetes between ages 13 and 20 years, compared with children of a similar age without type 1 diabetes.
Methods: All patients underwent a dual energy x-ray absorptiometry scan to measure body composition and a pulse wave test measure of arterial elasticity. Fasting serum lipid levels, apolipoprotein B, and apolipoprotein C-III levels were measured in each patient. Twenty-nine children with type 1 diabetes (10 girls, 19 boys) and 37 healthy children (18 girls, 19 boys) participated.
Results: Although no sex differences for body mass index (P = 0.91) and glycosylated hemoglobin (P = 0.69) were seen, girls with type 1 diabetes had a significantly higher percent trunk fat compared with boys (P = 0.004). No sex differences were found (P > 0.05) for percent trunk fat in adolescents without diabetes. There was no sex difference among any other cardiovascular risk factors in either children with or without diabetes.
Conclusions: Female adolescents with type 1 diabetes have more centrally distributed fat, which may contribute to their relatively higher cardiovascular disease risk. Attenuation of the central distribution of fat through exercise and dietary modifications may help ameliorate their subsequent cardiovascular disease burden.
Copyright © 2012 Elsevier HS Journals, Inc. All rights reserved.
References
-
- Laing SP, et al. The British Diabetic Association Cohort Study, II: cause-specific mortality in patients with insulin-treated diabetes mellitus. Diabetic Medicine. 1999;16(6):466–471. - PubMed
-
- Libby P, et al. Report of the National Heart, Lung, and Blood Institute-National Institute of Diabetes and Digestive and Kidney Diseases Working Group on Cardiovascular Complications of Type 1 Diabetes Mellitus. Circulation. 2005;111(25):3489–3493. - PubMed
-
- Laing SP, et al. The British Diabetic Association Cohort Study, I: all-cause mortality in patients with insulin-treated diabetes mellitus. Diabetic Medicine. 1999;16(6):459–465. - PubMed
-
- Nishimura R, et al. Mortality Trends in Type 1 Diabetes: The Allegheny County (Pennsylvania) Registry 1965-1999. 2001;24(5):823–827. - PubMed
-
- Swerdlow AJ, Jones ME. Mortality during 25 Years of Follow-Up of a Cohort with Diabetes. 1996;25(6):1250–1261. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
